Wegener's granulomatosis: Clinical manifestations, differential diagnosis, and management of ocular and systemic disease

Survey of Ophthalmology

Volumn 55, Issue 5, 2010, Pages 429-444

  Tarabishy, Ahmad B ^a   Schulte, Mark ^b   Papaliodis, George N ^c   Hoffman, Gary S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

ANCA; Necrotizing granuloma; Ocular manifestations of systemic disease; Sinonasal disease; Vasculitis; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ETANERCEPT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

CATARACT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONJUNCTIVITIS; DACRYOCYSTORHINOSTOMY; DIFFERENTIAL DIAGNOSIS; EAR DISEASE; EYE DISEASE; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LACRIMAL DUCT OCCLUSION; LUNG DISEASE; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; RADIOGRAPHY; RESPIRATORY TRACT DISEASE; REVIEW; SCLERITIS; SURVIVAL; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT; UVEITIS; WEGENER GRANULOMATOSIS;

EID: 77955336332     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.12.003     Document Type: Review

References (91)

1. Alloway J.A., Cupps T.R. High-dose methylprednisolone for retro-orbital Wegener's granulomatosis. J Rheumatol 1993, 20:752-754.
2. Belden C.J., Hamed L.M., Mancuso A.A. Bilateral isolated retrobulbar optic neuropathy in limited Wegener's granulomatosis. J Clin Neuroophthalmol 1993, 13:119-123.
3. Bertelmann E., Liekfeld A., Pleyer U., et al. Cytomegalovirus retinitis in Wegener's granulomatosis: case report and review of the literature. Acta Ophthalmol Scand 2005, 83:258-261.
4. Black R.L., Oglesby R.B., von Sallmann L., et al. Posterior subcapsular cataracts inducted by glucocorticoids in patients with rheumatoid arthritis. JAMA 1960, 174:166-171.
5. Blaise P., Robe-Collignon N., Andris C., Rakic J.M. Wegener's granulomatosis and posterior ischemic optic neuropathy: atypical associated conditions. Eur J Intern Med 2007, 18:326-327.
6. Bullen C.L., Liesegang T.J., McDonald T.J., et al. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983, 90:279-290.
7. Carlson J.A., Cavaliere L.F., Grant-Kels J.M. Cutaneous vasculitis: diagnosis and management. Clin Dermatology 2006, 24:414-429.
8. Cassells-Brown A., Morrell A.J., Davies B.R., et al. Wegener's granulomatosis causing lid destruction: a further sight-threateneing complication. Eye 2003, 17:652-654.
9. Charles S.J., Meyer P.A.R., Watson P.G. Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease. Br J Ophthalmol 1991, 75:201-207.
10. Chiquet C., Lumbroso L., Denis P., et al. Acute posterior multifocal placoid pigment epitheliopathy associated with Wegener's granulomatosis. Retina 1999, 19:309-313.
11. Courcoutsakis N.A., Langford C.A., Sneller M.C., et al. Orbital involvement in Wegener's granulomatosis: MR findings in 12 patients. J Comput Assist Tomogr 1997, 27:452-458.
12. De Groot K., Rasmussen N., Bacon P.A., et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52:2461-2469.
13. De Silva D.J., Cole C., Luthert P., et al. Masked orbital abscess in Wegener's granulomatosis. Eye 2007, 21:246-248.
14. Finkielman J.D., Merkel P.A., Schroeder D., et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener's granulomatosis. Ann Intern Med 2007, 147:611-619.
15. Fortney A.C., Chodosh J. Conjunctival ulceration in recurrent Wegener granulomatosis. Cornea 2002, 21:623-624.
16. Francois J. Glucocorticoid glaucoma. Ophthalmologica 1984, 188:76-81.
17. Freidlin J., Wong I.G., Acharya N. Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis. Br J Ophthalmol 2007, 91:1414.
18. Ghanem R.C., Chang N., Aoki L., et al. Vasculitis of the lacrimal sac wall in Wegener granulomatosis. Ophthal Plast Reconstr Surg 2004, 20:254-257.
19. Gordon L.K., Eggena M., Holland G.N., et al. pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 1998, 18:264-271.
20. Gordon L.K., Eggena M., Targan S.R., et al. Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA. Invest Ophthalmol Vis Sci 1999, 40:1250-1255.
21. Guillevin L., Cohen P., Gayraud M., et al. Churg-Strauss syndrome: Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78:26-37.
22. Haimovici R., Koh S., Gagnon D.R., et al. Risk factors for central serous chorioretinopathy. Ophthalmology 2004, 111:244-249.
23. Harman L.E., Margo C.E. Wegener's granulomatosis. Surv Ophthalmol 1998, 42:458-480.
24. Harper S.L., Letko E., Samson C.M., et al. Wegener's granulomatosis: the relationship between ocular and systemic disease. J Rheumatol 2001, 28:1025-1032.
25. Haynes B.F., Fishman M.L., Fauci A.S., et al. The ocular manifestations of Wegener's granulomatosis: fifteen years experience and review of the literature. Am J Med 1977, 63:131-141.
26. Hoffman G.S. Immunosuppressive therapy is always required for the treatment of Wegener's granulomatosis. Sarcoidosis Vasc Diffuse Lung Dis 1996, 13:249-252.
27. Hoffman G.S., Kerr G.S., Leavitt R.Y., et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
28. Hoffman G.S., Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998, 41:1521-1537.
29. Huong Du L.T., Tran T.H., Piette J.C. Granulomatous uveitis revealing Wegener's granulomatosis. J Rheumatol 2006, 33:1209-1210.
30. Iida T., Spaide R.F., Kantor J. Retinal and choroidal arterial occlusion in Wegener's granulomatosis. Am J Ophthalmol 2002, 133:151-152.
31. Jabs D.A., Mudun A., Dunn J.P., et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 2000, 130:469-476.
32. Janknecht P., Mittelviefhaus H., Loffler K.U. Sclerochoroidal granuloma in Wegener's granulomatosis simulating a uveal melanoma. Retina 1995, 15:150-153.
33. Jayne D., Rasmussen N., Andrassy K., et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349:36-44.
34. Jones R.B., Tervaert J.W.C., Hauser T., et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010, 363:211-220.
35. Kain R., Exner M., Brandes R., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 14:1088-1096.
36. Kalina P.H., Lie J.T., Campbell R.J., Garrity J.A. Diagnostic value and limitations or orbital biopsy in Wegener's granulomatosis. Ophthalmology 1992, 99:120-124.
37. Kamei M., Yasuhara T., Tei M., et al. Vitreous hemorrhage from a ciliary granuloma associated with Wegener granulomatosis. Am J Ophthalmol 2001, 132:924-926.
38. Kassan H., Cohavy O., Rosenbaum J.T., et al. Uveitis seroreactivity to candidate pANCA antigens: mycobacterial HupB and histone H1(69-171). Ocul Immunol Inflamm 2005, 13:191-198.
39. Keogh K.A., Wylam M.E., Stone J.H., et al. Induction of remission B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic-antibody associated vasculitis. Arthritis Rheum 2005, 52:262-268.
40. Keogh K.A., Ytterberg S.R., Fervenza F.C., et al. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006, 173:180-187.
41. Khan S.A., Subla M.R., Behl D., et al. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest 2007, 131:972-976.
42. Kwan A.S., Rose G.E. Lacrimal drainage surgery in Wegener's granulomatosis. Br J Ophthalmol 2000, 84:329-331.
43. Langford C.A., Hoffman G.S. Wegener's granulomatosis. Thorax 1999, 54:629-637.
44. Langford C.A., Talar-Williams C., Barron K.S., et al. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rates of relapse. Am J Med 2003, 114:463-469.
45. Leavitt J.A., Butrus S.I. Wegener's granulomatosis presenting as dacryoadenitis. Cornea 1991, 10:542-545.
46. Leavitt R.Y., Fauci A.S., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the diagnosis of Wegener's granulomatosis. Arthritis Rheum 1990, 33:1101-1107.
47. Levy-Clarke G., Ding X., Gangaputra S., et al. Recalcitrant granulomatous sclerouveitis in a patient with granulomatous ANCA-associated vasculitis. Ocul Immunol Inflamm 2009, 17:83-87.
48. Levy-Clarke G.A., Nussenblatt R. Retinal vasculitis. Int Ophthalmol Clin 2005, 45:99-113.
49. Loke Y.K., Tan M.H. An unusual case of Wegener's granulomatosis. Med J Malaysia 1998, 53:107-109.
50. Loredo A., Rodrigues R.S., Murillo L. Cataracts after short-term corticosteroid treatment. N Engl J Med 1972, 286:160.
51. Lovelace K., Cannon T.C., Flynn S. Optic neuropathy in a patient with Wegener's granulomatosis. J Ark Med Soc 2004, 100:428-429.
52. Lutt J.R., Lim L.L., Phal P.M., et al. Orbital inflammatory disease. Semin Arthritis Rheum 2008, 37:207-222.
53. Meier F.M., Messmer E.P., Bernauer W. Wegener's granulomatosis as a cause of cicatrizing conjunctivitis. Br J Ophthalmol 2001, 85:628.
54. Merkel P.A., Lo G.H., Holbrook J.T., et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005, 142:620-626.
55. Messmer E.M., Foster C.S. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379-396.
56. Mirza S., Raghu Ram A.R., et al. Central retinal artery occlusion and bilateral choroidal infarcts in Wegener's granulomatosis. Eye 1999, 13:374-376.
57. Miserocchi E., Waheed N.K., Baltatzis S., et al. Chronic cicatrizing conjunctivitis in a patient with ocular cicatricial pemphigoid and fatal Wegener granulomatosis. Am J Ophthalmol 2001, 132:923-924.
58. Niskopoulou M., Du Toit N. Optic neuritis as a feature of Wegener's granulomatosis. Eye 2002, 16:320-321.
59. Ognibene F.P., Shelhamer J.H., Hoffman G.S., et al. Pneumocystitis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 1995, 151:795-799.
60. Onal S., Kazokoglu H., Koc A., et al. Rixumab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis. Ocul Immunol Inflamm 2008, 16:230-232.
61. Pagnoux C., Mahr A., Hamidou M.A., et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 2008, 359:2790-2803.
62. Pakrou N., Selva D., Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 2006, 35:284-292.
63. Paul B., McElvanney A.M., Agarwal S., et al. Two rare causes of posterior ischaemic optic neuropathy: eosinophilic fascitis and Wegener's granulomatosis. Br J Ophthalmol 2002, 86:1066-1068.
64. Pecorella I., La Cava M., Mannino G., et al. Diffuse granulomatous necrotizing scleritis. Acta Ophthalmol Scand 2006, 84:263-265.
65. Provenzale J.M., Mukherji S., Allen N.B., et al. Orbital involvement by Wegener's granulomatosis: imaging findings. AJR Am J Roentgenol 1996, 166:929-934.
66. Reynolds I., Tullo A.B., John S.L., et al. Corneal epithelial-specific cytokeratin 3 is an autoantigen in Wegener's granulomatosis-associated peripheral ulcerative keratitis. Invest Ophthalmol Vis Sci 1999, 40:2147-2151.
67. Robinson M.R., Lee S.S., Sneller M.C., et al. Tarsal-conjunctival disease associated with Wegener's granulomatosis. Ophthalmology 2003, 110:1770-1780.
68. Samuelson T.W., Margo C.E. Protracted uveitis as the initial manifestation of Wegener's granulomatosis. Arch Ophthalmol 1990, 108:478-479.
69. Sandusky H., Cilluffo M., Braun J., et al. Ocular pANCA antigens are expressed in nonpigmented ciliary body epithelium and are conserved in multiple mammalian species. Ocul Immunol Inflamm 2001, 9:25-34.
70. Seo P., Specks U., Keogh K.A. Efficacy of rituxmib in limited Wegener's granulomatosis with refractory granulomatous manifestations. J Rheumatol 2008, 35:2017-2023.
71. Shields J.A., Shields C.L., Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 2004, 111:997-1008.
72. Skalka H.W., Prchal J.T. Effect of glucocorticoids on cataract formation. Arch Ophthalmol 1980, 98:1773-1777.
73. Specks U., Fervenza F.C., McDonald T.J., et al. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001, 44:2836-2840.
74. Stegeman C.A., Tervaert J.W., de Jong P.E., et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch co-trimoxazole study group. N Engl J Med 1996, 335:16-20.
75. Stegeman C.A., Tervaert J.W., Sluiter W.J., et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994, 120:12-17.
76. Stempel D., Sandusky H., Lampi K., et al. BetaB1-crystallin: identification of a candidate ciliary body uveitis antigen. Invest Ophthalmol Vis Sci 2003, 44:203-209.
77. Stone J.H. Vasculitis: a collection of pearls and myths. Rheum Dis Clin North Am 2007, 33:691-739.
78. Stone J.H., Holbrook J.T., Marriott M.A., et al. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis Rheum 2006, 54:1608-1618.
79. Stone J.H., Merkel P.A., Spiera R., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363:221-232.
80. Talar-Williams C., Sneller M.C., Langford C.A., et al. Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis. Br J Ophthalmol 2005, 89:493-497.
81. Tanihara H., Nakayama Y., Honda Y. Wegener's granulomatosis with rapidly progressive retinitis and anterior uveitis. Acta Ophthalmol (Copenh) 1993, 71:853-855.
82. Tullo A.B., Durrington P., Graham E., et al. Florid xanthelasmata (yellow lids) in orbital Wegener's granulomatosis. Br J Ophthalmol 1995, 79:453-456.
83. Vandergheynst F., Van Gansbeke D., Cogan E. Wegener's granulomatosis masquerading as a renal cancer: a case report and review of the literature. Clin Exp Rheumatol 2006, 24:584-586.
84. Venkatesh P., Chawla R., Tewari H.K. Hemiretinal vein occlusion in Wegener's granulomatosis. Eur J Ophthalmol 2003, 13:722-725.
85. Veyssier-Belot C., Cacoub P., Caparros-Lefebvre D., et al. Erdheim-Chester disease: Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996, 75:157-169.
86. Villa-Forte A., Clark T.M., Gomes M., et al. Substitution of methotrexate for cyclophosphamide in Wegener's granulomatosis. A 12-year single-practice experience. Medicine (Baltimore) 2007, 86:269-277.
87. Vogiatzis K.V. Bilateral blindness due to necrotizing scleritis in a case of Wegener's granulomatosis. Ann Ophthalmol 1983, 15:185-188.
88. Wang M., Khurana R.N., Sadda S.R. Central retinal vein occlusion in Wegener's granulomatosis without retinal vasculitis. Br J Ophthalmol 2006, 90:1435-1436.
89. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005, 352:351-361. Wegener's granulomatosis etanercept trial (WGET) research group.
90. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002, 23:450-468. WGET Research Group.
91. Woo T.L., Francis I.C., Wilcsek G.A., et al. Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology 2001, 108:1535-1543.